INHIBITORY CELL ADHESION SURFACES
Nanostructured surfaces on selected substrates are described which are highly resistant to cell adhesion. Such surfaces on medical implants inhibit fibroblast adhesion particularly on nanorough titanium deposited on smooth silicone surfaces. The nanostructured deposited metal coatings can also be engineered so that several cell types, including endothelial, osteoblast, and fibroblast cells, show little if any tendency to attach to the coated surface in vivo.
1 . An implant device comprising:
a substrate having a surface; and
a nanostructured coating applied to the surface, the coating resulting in a contact angle greater than about 50 degrees, wherein the value of the contact angle is such that cell attachment to the coating is reduced compared to cell attachment to an uncoated surface.
2 . The implant according to claim 1 , wherein the contact angle is higher for the coated surface than for the uncoated surface.
3 . The implant according to claim 1 , wherein the uncoated surface results in a contact angle less than 50 degrees.
4 . The implant device according to claim 1 , wherein the substrate comprises a non-metal.
5 . The implant according to claim 1 , wherein the coating results in a surface energy value, wherein the value of the surface energy is such that cell attachment to the coating is reduced compared to cell attachment to an uncoated surface.
6 . The implant according to claim 5 , wherein the surface energy value is higher for the coated surface than for the uncoated surface.
7 . The implant according to claim 1 , wherein the reduction of cell attachment is exhibited by fibroblast, endothelial, and osteoblast cells.
8 . The implant according to claim 7 , wherein the fibroblast cell comprises a periodontal ligament fibroblast (PLF), gingival fibroblast (GF), or a mixture of PLF and GF cells.
9 . The implant according to claim 1 , wherein the cell attachment to the coated surface is an order of magnitude less than cell attachment to the uncoated surface.